Als_Pipeline
-
In the pipeline: Biologic, TDI-143, targeting endothelial cell dysfunction moved into efficacy studies
12:43 PM May 17th
via TweetDeck
-
In the pipeline: Small molecule, TDI-154 , targeting Autophagy/Proteasome entered the vitro validation stage.
11:58 AM May 9th
via TweetDeck
-
Can the NeuRX delay NIV? Watchlist: French team rethinks the potential of the DPS
9:10 AM May 3rd
via web
-
Why is it so hard to develop medicines for ? Watchlist: The ABCs of ALS Therapies
10:56 AM Apr 27th
via web
-
Some neurologists do not recommend the new test for all ppl with . Learn why in our recent watchlist:
7:39 AM Apr 26th
via web
-
Quest Diagnostics Announces C9orf72 Genetic Test for (Lou Gehrig's Disease)
7:50 AM Apr 26th
via TweetDeck
-
XTRA!XTRA! @ puts Cytokinetics' CK-357 on the fast-track for
9:44 AM Apr 19th
via web
-
@ story discusses patients taking research into their own hands -
7:33 AM Apr 18th
via TweetDeck
-
Watchlist: transplantation may be safe. But are the anti-rejection drugs tolerable?
7:53 AM Apr 13th
via web
-
MT @ calls for further careful study of a high fat ketogenic diet using or other suppls
2:07 PM Apr 11th
via TweetDeck
-
Introducing XTRA!XTRA! The latest and/or underreported studies in in 2 tweets or less
6:59 AM Apr 10th
via web
-
IN BRIEF:Motor neurons made easy? A new pALS iPS line could be used to study and rapidly id new ALS drugs.
7:26 AM Apr 6th
via web
-
Interesting article on Biogen & dexpramipexole - "Lou Gehrig’s Disease May Bring Biogen $1 Billion Payoff"
10:21 AM Apr 4th
via TweetDeck
-
Exercise does a body good. But what about people with ? Experts weigh in.
11:01 AM Mar 28th
via web
-
Our latest webinar on TDI-132/Gilenya is now available online (Note: Must login to view)
9:56 AM Mar 14th
via web
-
Want to know more about the drug entering into Phase II clinical trial for ? Register 4 @'s webinar on 3/12:
9:18 AM Mar 9th
via TweetDeck
-
@ Using advncd MRI technques, researchers r begnning to recognize brain signatures that may indicate ALS:
8:27 AM Mar 9th
via TweetDeck
in reply to MautryMichael
-
The 23rd International Symposium on will be held in Chicago, USA on 5-7 Dec 12. Hashtag to use is
6:55 AM Mar 8th
via web
-
CNS drugs take on average 40% longer to evaluate in clinical trials according to a new study from Tufts’s CSDD-
5:56 AM Mar 8th
via TweetDeck
-
Cytokinetics Announces EMA Has Granted CK-2017357 Orphan Medicinal Product Designation for Treatment of (release)
1:37 PM Mar 6th
via TweetDeck
|
- Name Als Pipeline
- Location Cambridge, MA
- Web http://www.als.net
- Bio Tweets on #ALS news and research. A service provided by ALS Therapy Development Institute (ALS TDI).
|